AbCellera Biologics Inc. ABCL Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s restricted cash?
- AbCellera Biologics Inc. (ABCL) reported restricted cash of $25M in Q1 2026.
- How has AbCellera Biologics Inc.'s restricted cash changed year-over-year?
- AbCellera Biologics Inc.'s restricted cash decreased by 0.0% year-over-year, from $25M to $25M.
- What is the long-term trend for AbCellera Biologics Inc.'s restricted cash?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s restricted cash has grown at a 0.0% compound annual growth rate (CAGR), from $25M to $25M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.